{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:20:15Z","timestamp":1793420415642,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.10.015","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T17:23:59Z","timestamp":1195061039000},"page":"8500-8507","source":"Crossref","is-referenced-by-count":117,"title":["Factors influencing the antibody response of dogs vaccinated against rabies"],"prefix":"10.1016","volume":"25","author":[{"given":"Lorna J.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"McElhinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Fooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.R.","family":"Ollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.10.015_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0264-410X(99)00247-9","article-title":"Immunization of dogs with a DNA vaccine induces protection against rabies virus","volume":"18","author":"Perrin","year":"1999","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2007.10.015_bib2","first-page":"428","article-title":"Rabies antibody testing and the UK pet travel scheme","volume":"150","author":"Fooks","year":"2002","journal-title":"Vet Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.015_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Meth"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.10.015_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0034-5288(02)90071-8","article-title":"Serological response to rabies vaccination for the pet travel scheme","volume":"72","author":"Burr","year":"2002","journal-title":"Res Vet Sci"},{"issue":"15","key":"10.1016\/j.vaccine.2007.10.015_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/vr.141.15.380","article-title":"Outbreak of canine distemper in vaccinated dogs in Finland","volume":"141","author":"Ek-Kommonen","year":"1997","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2007.10.015_bib6","series-title":"Veterinary immunology","author":"Tizard","year":"1996"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.015_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2885.1997.00050.x","article-title":"Adverse reactions to veterinary drugs reported in Sweden during 1991\u20131995","volume":"20","author":"Tjalve","year":"1997","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2007.10.015_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/vr.154.14.423","article-title":"Factors affecting the serological response of dogs and cats to rabies vaccination","volume":"154","author":"Mansfield","year":"2004","journal-title":"Vet Record"},{"key":"10.1016\/j.vaccine.2007.10.015_bib9","unstructured":"Kennedy LJ, Davison LJ, Barnes A, Isherwood D, Ollier WER, Catchpole B. Susceptibility to canine diabetes mellitus is associated with MHC class II polymorphism. BSAVA annual congress 2003 scientific proceedings 2003. p. 593."},{"key":"10.1016\/j.vaccine.2007.10.015_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1399-0039.2005.00518.x","article-title":"Association of Hypothyroid disease in Doberman Pinscher dogs with a rare Major Histocompatibility Complex DLA class II haplotype","volume":"67","author":"Kennedy","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2007.10.015_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1399-0039.2006.00614.x","article-title":"Association of canine Hypothyroidism with a common Major Histocompatibility Complex DLA class II allele","volume":"68","author":"Kennedy","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2007.10.015_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s002510100372","article-title":"Dog MHC alleles containing the \u201chuman RA shared epitope\u201d confer susceptibility to canine rheumatoid arthritis","volume":"53","author":"Ollier","year":"2001","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.015_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00251-003-0545-1","article-title":"Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism","volume":"55","author":"Quinnell","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2007.10.015_bib14","series-title":"Modern methods of data analysis","first-page":"58","article-title":"Describing univariate distributions","author":"Fox","year":"1990"},{"key":"10.1016\/j.vaccine.2007.10.015_bib15","series-title":"Hepatitis B vaccines in clinical practice","year":"1993"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.015_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00003495-200363100-00006","article-title":"Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B","volume":"63","author":"Keating","year":"2003","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.015_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1010046532657","article-title":"Longevity and the immune response","volume":"1","author":"Aspinall","year":"2000","journal-title":"Biogerontology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.015_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08916938809001927","article-title":"Ageing and autoantibodies","volume":"1","author":"Tomer","year":"1988","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.015_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"Rupprecht","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.015_bib20","unstructured":"Wilsmore T, Hamblin C, Taylor N, Taylor W, Watson B. Qualitative veterinary risk assessment of the introduction or rabies into the United Kingdom. A report prepared for Defra (Department for the Environment, Food and Rural Affairs) 2006: http:\/\/www.defra.gov.uk\/animalh\/diseases\/notifiable\/rabies\/pdf\/qra-rabies.pdf."},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.015_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2460\/javma.1990.197.02.201","article-title":"Epidemiologic factors, clinical findings, and vaccination status of rabies in cats and dogs in the United States in 1988. National Study Group on Rabies","volume":"197","author":"Eng","year":"1990","journal-title":"J Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.015_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1034\/j.1399-0039.2002.590303.x","article-title":"Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs","volume":"59","author":"Kennedy","year":"2002","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.015_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1399-0039.2002.600106.x","article-title":"Evidence for extensive DLA polymorphism in different dog populations","volume":"60","author":"Kennedy","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2007.10.015_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-2427(99)00046-X","article-title":"Interbreed variation of DRB1, DQA1 alleles and haplotypes in the dog","volume":"69","author":"Kennedy","year":"1999","journal-title":"Vet Immunol Immunopathol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T21:31:45Z","timestamp":1708291905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07011541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":24,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07011541"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}